Novel plasma biomarkers improve discrimination of metabolic health independent of weight
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-78478-w
Abstract: We sought to determine if novel plasma biomarkers improve traditionally defined metabolic health (MH) in predicting risk of cardiovascular disease (CVD) events irrespective of weight. Poor MH was defined in CATHGEN biorepository participants (n > 9300), a… read more here.
Keywords: plasma biomarkers; plasma; metabolic health; novel plasma ... See more keywords
Novel plasma biomarkers in arrhythmogenic cardiomyopathy: the role of ST2 and GDF-15 in predicting biventricular involvement
Sign Up to like & getrecommendations! Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.0728
Abstract: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disease characterized by fibrofatty replacement of the myocardium and ventricular arrhythmias. Biventricular (BiV) involvement in ARVC may lead to heart failure. This study aimed to… read more here.
Keywords: arvc; plasma biomarkers; sst2 gdf; novel plasma ... See more keywords
Abstract 4135: A novel plasma cell-based mechanism of action of adenosine immunomodulation and A2AR antagonism
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-4135
Abstract: High levels of extracellular adenosine, often found in the tumor microenvironment (TME), promote immune suppression mainly through the A2A receptor (A2AR) expressed by tumor-infiltrating immune cells. Inupadenant (formerly known as EOS100850) is an oral, non-brain… read more here.
Keywords: cell; plasma cell; mechanism action; plasma ... See more keywords